Back to Agenda
Session 2: Patient Perspectives on the Risks and Benefits of Opioid Therapy
Session Chair(s)
Robert Pratt
Risk Management Analyst, FDA, United States
Balancing the risks of opioid therapy with the benefits is an ongoing challenge as prescription opioids continue to contribute to the US opioid crisis. This session examines the patient's understanding, attitudes, and experiences with opioids including concepts of misuse and abuse, communication of risk, and the benefit-risk perspective. Panelists will also discuss strategies to minimize risk as well as challenges with patient engagement in this setting.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the patient’s perspective, experiences, and informational needs about opioids
- Describe a self-reported measure to identify opioid abuse and misuse behaviors
- Understand risk assessment and mitigation strategies for the use of opioids in patients with chronic pain
Speaker(s)
Martin Cheatle, PHD
Associate Professor of Psychology in Psychiatry, Perelman School of Medicine, University of Pennsylvania, United States
Karin Coyne, PHD, MPH
Vice President, Research, Evidera, United States
Nicole Kelly
, American Chronic Pain Association, United States
Paula Rausch, PHD, RN
Director, Division of Health Communications, Office of Communications, CDER, FDA, United States
Have an account?